Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Tacrolimus × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 169 Lymphoid 125 Myeloid 112 Plasma cell 61 Classical hematology 31 Dermatologic 20 Sarcoma 19 Genitourinary 8 Other neoplasm 6 CNS 6 Gastrointestinal 4 Breast 2 Tumor-Agnostic 1 Thoracic 1 Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 960 Cisplatin 759 Pemetrexed 705 pembrolizumab 519 Paclitaxel 497 Docetaxel 457 Gemcitabine 353 Radiotherapy 337 Erlotinib Hydrochloride 323 Bevacizumab 282 Nivolumab 277 Etoposide 244 durvalumab 223 Drug Therapy 207 osimertinib 197 atezolizumab 187 Radiosurgery 162 Gefitinib 152 Vinorelbine 131 Magnetic Resonance Spectroscopy 116 Ipilimumab 103 130-nm albumin-bound paclitaxel 103 Cetuximab 95 Topotecan 89 Surgical Procedures, Operative 88 Cyclophosphamide 87 Specimen Handling 85 tislelizumab 82 Irinotecan 81 anlotinib 78

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06120140 2026-03-13

COCOON

Janssen Research & Development, LLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡